Oculis Expands Portfolio with a Novel Phase II-stage Anti-TNF alpha Antibody Fragment

04 January, 2019

Oculis Raises CHF15.5 million in an Extension of its Series B Financing Round

04 January, 2019

Oculis Strengthens its Global Clinical and Business Development Capabilities

20 November, 2018

Oculis appoints Pravin U. Dugel, M.D. as Chairman of its Scientific Advisory Board

25 September, 2018

Oculis elects Anthony Rosenberg David A. Weber to its Board of Directors

19 September, 2018

Oculis Raises CHF20 million in a Series B Financing Round to Advance Treatments

01 January, 2018

Prof. Stefansson awarded Peter Watson prize and chair of Cambridge Ophtha. symposium

27 September, 2017

Eye-drop for Diabetic Retinopathy – Successful Eurostars grant application

27 June, 2017

ARVO 2017 – two poster presentations

12 May, 2017